Acute Investment Advisory’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History

Acute Investment Advisory’s Portfolio IGIB Stock Details IGIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,783	Closed	-$701K	–	36
2022 Q1	$701K	Sell	12,783 -139,036	-92%	-$7.88M	0.52%	29
2021 Q4	$9M	Buy	+151,819	New	+$9.04M	6.57%	4

Other funds holding IGIB

Financial Engines Advisors Santa Clara, California $56.3B AUM 17.83% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MYLI

Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DILIC

Dai-ichi Life Insurance Company Tokyo, Japan $4.28B AUM 43.07% 1-Year Est. Return

Acute Investment Advisory's IGIB Position: Q2 2022 in Review

Acute Investment Advisory sold out of iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) in Q2 2022, closing a stake of 12,783 shares — an estimated $701K sold.

Acute Investment Advisory first reported a position in IGIB in Q4 2021 and held it in 2 quarters. The position peaked at $9M in Q4 2021. 519 funds tracked by Wall St. Rank hold IGIB as of Q2 2022.

Acute Investment Advisory reported no remaining iShares 5-10 Year Investment Grade Corporate Bond ETF position as of Q2 2022 after selling out during the quarter.
Acute Investment Advisory sold 12,783 iShares 5-10 Year Investment Grade Corporate Bond ETF shares in Q2 2022, an estimated $701K.
Acute Investment Advisory first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q4 2021 and held it in 2 quarters.
Acute Investment Advisory's iShares 5-10 Year Investment Grade Corporate Bond ETF position peaked at $9M in Q4 2021.
519 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q2 2022.

Based on Acute Investment Advisory's 13F filing for Q2 2022, filed 31 Aug 2022.